Graphical Abstract Highlights d Triazolopyrimidines are microtubule stabilizers targeting the tubulin vinca site d Triazolopyrimidines stabilize longitudinal tubulin contacts d Triazolopyrimidines are not affected by p-glycoprotein overexpression
INTRODUCTION
The ab-tubulin heterodimer and its assembly product, the microtubule, are among the most successful targets in cancer chemotherapy (Dumontet and Jordan, 2010) . Since two important microtubule-dependent functions, chromosome segregation and maintenance of cell shape and motility, are required for cell division and angiogenesis, respectively, compounds targeting microtubules affect essential processes that are needed for tumor growth. However, despite the successes of microtubule-targeting agents (MTAs) in the clinic (e.g., vinca alkaloids, auristatins, taxanes, epothilones, eribulin, maytansine [Mukhtar et al., 2014] ) the appearance of resistance against MTAs has triggered the search for new compounds with alternative mechanisms of action and/or improved chemical properties.
A key property underlying microtubule function is their dynamic behavior that is controlled by guanosine triphosphate (GTP) hydrolysis on b-tubulin. Any compound interfering with microtubule dynamics is a potential anti-mitotic agent (Jordan and Wilson, 2004) . Tubulin modulators may work either by mimicking the intrinsic assembly/disassembly process or by preventing/facilitating lateral and/or longitudinal contacts between tubulin dimers in microtubules. Paclitaxel-site ligands bind to a hydrophobic cleft of the b-tubulin subunit and often induce the structuring of a key loop (the so-called M loop) that mediates lateral tubulin interactions in microtubules . The other family of activators that belongs to the laulimalide/peloruside class of MTAs bind to the interprotofilament interface between two adjacent tubulin dimers and thus act through a tubulin crosslinking mechanism . The vinblastine-and maytansine-site inhibitors, as well as eribulin, in turn bind to the b-tubulin subunit at the interdimer interface, thus perturbing (vinblastine) or blocking longitudinal tubulin contacts (eribulin) and favoring tubulin-tubulin association in a non-microtubule-like assembly fashion (Doodhi et al., 2016; Gigant et al., 2005; Prota et al., 2014a) .
[1,2,4]Triazolo [1,5-a] pyrimidines (referred to hereafter as TPs) are a rather unexplored class of MTAs. They are structurally related to BAS600F, a molecule that has been developed at BASF as a fungicide (Crowley et al., 2010) . One TP derivative, cevipabulin (TTI-237), a former anti-cancer drug candidate developed by Wyeth, has been proposed as a new type of microtubule-active compound. Cevipabulin inhibits the depolymerization of microtubules by cold and Ca 2+ , which is a paclitaxel-like activity. At the same time, the compound competes with vinblastine for tubulin binding. However, cells incubated with cevipabulin display a vinca-like phosphoprotein signature and thus exhibit mixed properties between paclitaxel and vinblastine (Beyer et al., 2008; Beyer et al., 2009; Lou et al., 2014; Zhang et al., 2007) . Finally, TPs display promising activities on tumors that are resistant to chemotherapy (Beyer et al., 2009) . In this study, we present an extensive biochemical, cell biology, and structural biology study of a group of TPs (denoted compounds 1-5; see Figure 1 ) (Lamberth et al., 2006) with the aim of shedding light on the molecular mechanism of action of this class of MTAs on tubulin and microtubules.
RESULTS AND DISCUSSION

Effects of TPs on Cells
First, the ability of 1-5 to kill tumor cells was tested in comparison with paclitaxel and vinblastine. All of these compounds were cytotoxic in A2780 ovarian carcinoma cells and its multidrugresistance counterpart A2780AD, with half-maximal inhibitory concentrations (IC 50 ) in the submicromolar concentration range (paclitaxel IC 50 A2780 0.8 ± 0.1 nM, A2780AD 600 ± 100 nM, resistant cells IC 50 /sensitive cells IC 50 (R/S) 750; 1 IC 50 A2780 51 ± 6 nM, A2780AD 81 ± 5 nM, R/S 1.6; 2 IC 50 A2780 200 ± 40 nM, A2780AD 250 ± 10 nM, R/S 1.3; 3 IC 50 A2780 250 ± 20 nM, A2780AD 330 ± 10 nM, R/S 1.32; 4 IC 50 A2780 600 ± 100 nM, A2780AD 630 ± 50 nM, R/S 1.05; 5 IC 50 A2780 430 ± 50 nM, A2780AD 620 ± 20 nM, R/S 1.45; vinblastine IC 50 A2780 0.17 ± 0.02 nM, A2780AD 46 ± 5 nM, R/S 270). These values are very similar to those described for cevipabulin (Beyer et al., 2009) . Interestingly, all of them are highly active in the multidrug-resistant cell line A2780AD, which expresses high levels of the p-glycoprotein. Moreover, while the resistance index of those cells for cevipabulin is approximately 25 (Beyer et al., 2009) compared with 750 for paclitaxel (Beyer et al., 2009) , the resistance index for 1-5 is below 2. This result suggests that compounds 1-5 are even worse substrates for the p-glycoprotein than cevipabulin. Since many MTAs able to overcome p-glycoprotein-mediated multidrug resistance are covalent binders (Buey et al., 2007; Field et al., 2012; Usui et al., 2004) , we tested the reversibility of the effect of 1 in Aspergillus nidulans cultures (Horio and Oakley, 2005) . Incubation of the fungus with 1 induced the formation of tubulin aggregates ( Figure S1 , upper panels), which are fully reversible after 30 min of incubation with fresh medium ( Figure S1 , lower panels), thus indicating a reversible mode of action of TP.
The cellular mechanism of action of compounds 1-5 was studied using cell cycle and immunofluorescence experiments. We first studied whether the compounds are able to block A549 lung carcinoma cells in the G 2 /M phase of the cell cycle after 20 hr of incubation ( Figure S2 ). All five compounds stopped cells in the G 2 /M phase, indicating an anti-mitotic mode of action. The minimal concentration of a given compound that is required to completely stop the cell cycle ( Figure S2 ) was concordant with the IC 50 data and indicated that 1 is the most active TP compound.
We next studied the effect of 1-5 on the microtubule cytoskeleton of lung carcinoma A549 cells. To this end, cells were incubated for 24 hr with paclitaxel, vinblastine, or 1-5. The immunofluorescence images clearly point out that the compounds target the microtubule cytoskeleton and induce the formation of dense microtubule bundles ( Figure 2 ), a structural feature typical of MSAs. Despite previous claims of TTI-237 competition with vinblastine-site ligands (Beyer et al., 2009) , the cellular effects of 1-5 are completely different from those observed with vinblastine, which completely disintegrates the cytoplasmic microtubule network ( Figure 2B) . Additional experiments at higher vinblastine concentrations resulted in the formation of characteristic vinblastine-induced paracrystals (Jordan et al., 1992) ( Figure 2I ). However, it should be mentioned that differences are observed between cells treated with 1-5 ( Figures  2D, 2E , 2F, 2G, and 2H) and those treated with paclitaxel (Figure 2C) . While the mitotic cells treated with the compounds showed small multipolar spindles, those treated with paclitaxel show noticeably larger mitotic spindles with one or two poles (Evangelio et al., 1998) .
To confirm the nature of the observed bundles, we obtained thin sections of the treated cells and evaluated and compared the effect of paclitaxel and 1 by electron microscopy ( Figures  2J, 2K , 2L, and 2M). The data revealed that the bundles induced by 1 were indeed composed of microtubules ( Figures 2K and 2L) , to those induced by paclitaxel ( Figure 2M ), but very different to polymers induced by vinblastine ( Figure 2N ). These observations indicate that under the conditions employed (1-20 mM compound concentration), 1 displays an MSA-like activity on cytoplasmic microtubules.
Effect of TPs on Tubulin and Microtubules In Vitro
Once we had established that 1-5 target the microtubule cytoskeleton, we performed biochemical studies to determine their 
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(A and B) Bar graphs showing the tubulin concentration in the supernatant of 20-mM tubulin samples incubated for 30 min at 37 C with 22 mM of the ligands podophyllotoxin (POD), vinblastine (VIN), docetaxel (DOC), 1-5, or DMSO (2.5%; vehicle) in (A) GAB and (B) PEDTA7 after 20 min of centrifugation in a TLA100 rotor at 50.000 rpm in an Optima TLX centrifuge. Inset: dependence of tubulin polymerization in the tubulin concentration, in the absence (squares) or presence (circles) of 1. Filled symbols, tubulin in pellet; open symbols, tubulin in supernatant. Lines are best regressions in the absence (dashed) or presence (solid) of 1. Error bars are SEs of triplicate measurements. (C and D) Electron micrographs of samples of 20 mM tubulin incubated for 30 min at 37 C with 22 mM of the ligand in (C) GAB or (D) PEDTA7. Scale bars represent 100 nm. (E) X-ray scattering profile of the polymers of tubulin assembled in the presence of 1 (black line) in GAB at 37 C. (F) Electron micrograph of a sample of 20 mM tubulin incubated for 30 min in GAB at 37 C to induce assembly into microtubules, after which 22 mM 1 was added and the sample further incubated for 1 hr at 37 C. Red arrows indicate microtubule distortions at their ends. Scale bar represents 100 nm. (G) Cold stabilization of microtubules by 1. Turbidity time course of assembly of 20 mM tubulin in GAB and followed at 350 nm. At 40 min, DMSO (vehicle, black line), 22 mM paclitaxel (red line), 22 mM 1 (blue line), or 22 mM podophyllotoxin (green line) were added. After 70 min, the temperature of the plate was reduced to 4 C. (H) GDP stabilization of microtubules by 1. Turbidity time course of assembly 20 mM tubulin in GAB followed at 350 nm. After 20 min, DMSO (vehicle, black line), 22 mM paclitaxel (red line), 22 mM 1 (blue line), or 22 mM podophyllotoxin (green line) were added. After 90 min, 10 mM GDP was added. mode of action on tubulin and microtubules. Firstly, the effect of 1 on tubulin polymerization was studied both in glycerol-containing (in which tubulin spontaneously assembles into microtubules) and glycerol-free (in which control electron microscopy experiments indicate that tubulin in concentrations up to 200 mM is unable to assembly in the absence of an MSA) buffers (Figures 3A and 3B) . The results
show that under the conditions tested, 1-5 are able to increase the polymer mass formed by decreasing the amount of unpolymerized tubulin, in contrast to colchicine site microtubule inhibitors (podophyllotoxin) or microtubule interfacial binders (vinblastine), which in the conditions of the assay induce aggregates that are too small to be pelleted (not shown). The polymerization behavior of tubulin in the presence of 1 (inset in Figure 3A ) reveals the requirement of a critical concentration, which suggests that the ligand induces tubulin polymerization following a classical nucleation-condensation type of mechanism (Oosawa and Asakura, 1975) . Electron microscopy and small-angle X-ray scattering (SAXS) studies were subsequently performed to assess the morphology of the polymers (Figures 3C, 3D , and 3E). Interestingly, the specimens formed in the presence of 1-5 were not microtubules, neither in the absence nor in the presence of glycerol. Instead, helical polymers and curved oligomers were observed, indicating that 1 perturbs the polymerization process of tubulin into microtubules under the conditions tried. The X-ray scattering profile obtained on the polymers in the presence of 1 ( Figure 3E ) showed the characteristic peaks expected for a helical polymer . The analysis of the positions of the J 0,1 and J 1,1 peaks allowed the determination of the average helix diameter and pitch ; the polymers induced by 1 showed an average helix diameter and a pitch of 360 ± 20 Å and 235 ± 25 Å , respectively.
Given the fact that the polymers observed in cells treated with 1-5 are microtubules, we decided to further investigate the morphology of the tubulin polymers assembled in vitro as a function of the ligand:tubulin stoichiometry, buffer conditions, and the presence of microtubule-associated proteins. For this, electron micrographs of the specimens obtained either from 20 mM purified tubulin in GAB buffer (see STAR Methods) or from 2 mg/mL microtubule proteins (tubulin co-purified together with microtubule-associated proteins [de Pereda et al., 1995] ) in 100 mM 2-(N-morpholino)ethanesulfonic acid, 1 mM EGTA, 1 mM MgSO 4 , 2 mM 2-mercaptoethanol, 1 mM GTP (pH 6.5) at 1:1 or 1:20 molar ratios between 1 and tubulin were recorded. The results indicate that tubulin assembled into microtubules, when a molar ratio of 20:1 of tubulin versus 1 was used, while it formed spirals when a molar ratio of 1:1 was employed (not shown). The content of 1 into the tubulin polymers was analyzed by high-performance liquid chromatography (HPLC). The results indicate that the compound incorporates into the polymers at a 0.6 ± 0.1 molar ratio with tubulin when incubated at a 1:1 molar ratio, while in the case of the polymers assembled at a molar ratio of 1:20 all of the compound was incorporated. Overstoichiometric ratios (up to 4:1) of all the compounds tested with tubulin does not significantly increase the amount of ligand found in the polymers. The polymers induced at a 1:1 stoichiometric ratio of compound versus tubulin displayed stoichiometries of 0.6 ± 0.1, 0.7 ± 0.1, 0.8 ± 0.1, 0.6 ± 0.1, and 0.7 ± 0.1 for 1, 2, 3, 4, and 5, respectively.
Finally, the effect of the order of addition of the drugs on the structure of the assembled polymers was tested. Therefore, 20 mM purified tubulin in GAB buffer was incubated at 37 C for 45 min, then 20 mM of 1 was added and the mixture was further incubated for another 45 min at 37 C. The structures of the specimens were subsequently assessed by electron microcopy ( Figure 3F ). We found that under these experimental conditions, the polymers were microtubules that display distortions at their ends (labeled by red arrows in Figure 3F ). This result indicates that the stabilization effect of TPs does not alter the structure of the preformed microtubules as is the case in cells (see above). To confirm the incorporation of the drug into the microtubules they were pelleted and analyzed by HPLC. We found that 12.8 ± 0.8 mM of 1 co-sediments with 20 mM of microtubules, which translates into a stoichiometry of 0.65 ± 0.05, a value that is almost identical to the one found for tubulin spirals (see above). Interestingly, when the same experiment was performed in the presence of vinblastine, only small amounts of the ligand were incorporated into preassembled microtubules: only 3.2 ± 0.2 mM of vinblastine co-pelleted together with microtubules. Taken together, these results suggest that in contrast to vinblastine, which can only bind to microtubule ends (Jordan et al., 1986; Wilson et al., 1975; Wilson et al., 1982) , TPs can also bind and stabilize the wall of preassembled microtubules.
The capacity of compound 1 to stabilize microtubules against cold and guanosine diphosphate (GDP) was tested in a polymerization assay. To this end, 20 mM tubulin in GAB buffer was assembled into microtubules by raising the temperature to 37 C ( Figures 3G and 3H ). After polymerization, 22 mM paclitaxel, 1, podophyllotoxin, or the equivalent amount of DMSO (vehicle) was added and the turbidity was monitored. As expected, disassembly was observed in the presence of podophyllotoxin either when the temperature was changed to 4 C or upon addition of 10 mM GDP to the solution. In the presence of paclitaxel or 1, microtubules were found to be more resistant to cold or GDP while those incubated with the vehicle did fully disassemble. Appropriate electron microscopy controls (not shown) were performed to confirm that the stable polymers were indeed microtubules.
Since binding of the compounds alters the polymer mass, we used stabilized crosslinked microtubules to estimate the binding constant of the compounds to microtubules using the centrifugation method described previously (Buey et al., 2005) . We found that the compounds are unable to bind to stabilized microtubules (not shown).
Mapping the Tubulin-Binding Site of TPs
To elucidate the binding site of TPs on tubulin, we performed competition assays with a fluorescent paclitaxel derivative Flutax-2 (Buey et al., 2005) and laulimalide (Pryor et al., 2002) , and found that 1-5 do not compete with these two classical MSAs (not shown). This result suggests that TPs do not target the paclitaxel-or laulimalide/peloruside sites on microtubules. Competition experiments with MTC , a bona fide probe of the colchicine site, indicated lack of competition with TPs (not shown).
Finally, we tested whether 1-5 bind to a complex formed between tubulin and the stathmin-like protein RB3. RB3 sequesters two longitudinally aligned tubulin dimers into a ternary and assembly-incompetent T 2 R complex (Gigant et al., 2000) , by binding to a region of the tubulin molecule which is located remote from the vinblastine site (Gigant et al., 2000) . The binding of 1-5 to T 2 R in equilibrium with unassembled tubulin was studied using analytical ultracentrifugation. As shown in Figure 4A , in this experiment no traces of compound were detected to be bound to unassembled tubulin dimers (6 S peak). However, 5.1 mM of compound present in the sample was bound to the T 2 R complex (9 S peak), indicating that 1.1 molecules of 1 are bound per T 2 R complex, or 0.55 molecules per tubulin dimer. A substantial amount of the compound was found to be bound to higher-order oligomers and aggregates.
The results obtained indicate that the TP binding site does not overlap with those of classical MSAs (taxanes or laulimalides); however, it is interfacial and located between two consecutive longitudinal associated tubulin subunits.
Modulation of Tubulin Oligomerization by TPs
The fact that 1-5 bind to the T 2 R complex, but not to tubulin dimers, suggests that they bind to a composite site formed at the longitudinal interdimer interface, which is in line with the observed enhancement of tubulin self-association in the presence of TPs. To test this hypothesis, we investigated the ligand-induced oligomerization process further by nuclear magnetic resonance (NMR) and additional analytical ultracentrifugation experiments. Figure 4B shows the diffusion-ordered spectroscopy (DOSY) spectra of 15 mM tubulin in the presence of 1 up to concentrations of 30 mM. The data reveal that the average diffusion coefficient of the sample decreased from 5 3 10 À11 m 2 s À1 in the absence of any ligand (a value similar to the previously determined 4.5 3 10 À11 m 2 s À1 [Krouglova et al., 2004] ) to 2.5 3 10 À11 m 2 s À1 in the presence of 30 mM 1, indicating a significant in-crease of the average size of the molecule species. Analysis of the dependence of the diffusion coefficient indicates that this parameter increases with increased concentrations of the ligand to reach a maximum at equimolecular concentrations ( Figure 4B , inset).
We next performed analytical ultracentrifugation experiments to discriminate between the different species present in the tubulin samples in the presence of 1. Figure 4C shows the effect of increasing concentrations of 1 on the oligomerization state of tubulin at a protein concentration of 30 mM. At a concentration of 1.5 mM MgCl 2 , tubulin is in the dimeric state (6 S peak) in the absence of any ligand (black line). In the presence of 15 mM 1, a series of species with sedimentation coefficients between 8 and 25 S were observed, especially those with coefficients between 15 and 25 S while dimer concentrations were strongly reduced. Increased concentrations of 1 did not further decrease the concentration of the dimeric species, but did so in those with sedimentation coefficients between 8 and 15 S. In fact, in the presence of an excess of ligand the average size of the formed species was 500 ± 200 kDa, a molecular mass that corresponds to 5 ± 2 tubulin dimers. Inspection of such samples by electron microscopy indicated that no large polymers were formed under these conditions.
Since 1 absorbs at 320 nm, it was possible to directly monitor its behavior during analytical ultracentrifugation analyses (Figure 4D) . The data revealed that the ligand was exclusively associated to the oligomeric species rather to the tubulin dimer, in full agreement with experiments performed with the T 2 R complex (see above). Together, these data suggest that 1 is an interfacial tubulin ligand.
The effect of solution conditions (temperature, type of nucleotide) and the reversibility of the induced oligomerization were checked by performing oligomerization experiments employing GDP-tubulin ( Figure S3A ), or GTP-tubulin at 4 C ( Figure S3B) , and by chelation of the required Mg 2+ ion by EDTA ( Figure S3C ). The results indicate that the oligomerization induced by the ligand depends on GTP and the temperature, like the normal microtubule assembly process, and that this oligomerization can be reverted upon chelation of Mg 2+ . While in the presence of GTP, tubulin rapidly forms large oligomers with sedimentation coefficients between 15 and 25 S ( Figure 4C) , and in the presence of GDP the protein accumulates in small oligomers with sedimentation coefficients of 8 and 10 S ( Figure S3A ); larger oligomers are only observed at high ligand concentrations. The experiments performed at 4 C indicate that tubulin remains mainly dimeric in these conditions (s 4,w = 3.4 S equivalent to s 20,w = 5.6 S) and only a small proportion of small oligomers (tetramers and hexamers) are visible at high ligand concentrations ( Figure S3B ). Finally, the ligand-induced oligomerization was found to be reversible; the addition of an excess (2 mM) of EDTA to a solution of 30 mM tubulin previously incubated with 1 in PEDTA1.5 (similar conditions to those employed at Fig-ure 4C) was able to dissociate the oligomers, so the dimer was again the main species detected ( Figure S3C ).
Affinities of the Tubulin-TP Interactions
The data described above reveal that compounds 1-5 only bind to oligomeric tubulin species and not to the unassembled dimer. Therefore, they heavily influence the oligomerization equilibrium, which implies that a direct determination of the binding affinity becomes very difficult because of the linkage between binding and oligomerization.
The binding equilibrium comprises the binding step itself and the oligomerization step. To obtain the values of the equilibrium constants, one should know the exact concentrations of all the involved species. However, such evaluations are not easily accessible using classical centrifugation-or fluorescence-based methods, since these techniques cannot distinguish between the dimeric and oligomeric species. Instead, kinetic or analytical ultracentrifugation methods can be employed. Kinetic methods can isolate one specific species provided that the kinetic step involved is the rate-limiting one. On the other hand, analytical ultracentrifugation methods may resolve the associated oligomerization equilibrium along with the analytical solution of the involved binding constants. In our case, the binding kinetics were analyzed by following the increase in the fluorescence of the sample at 460 nm upon excitation at 320 nm. In both cases, the reaction follows a monoexponential curve ( Figure 5A ) whose kinetic rates increase with the ligand concentration ( Figure 5B) .
The relationship of the kinetic rates with the ligand concentration depends on the type of reaction. In the case of a monomolecular reaction, it would be expected that the apparent kinetic rate depends linearly on the ligand concentration (Head et al., 1985) , which is not observed here. The observed behavior of the kinetic rate with the ligand concentration can be better modeled as a two-step reaction: the first one is fast and bimolecular, while the second one is slow and monomolecular.
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In this case, the dependence of the observed kinetic rates k ap follows the equation (Díaz et al., 2000; Head et al., 1985) :
where K a1 is the affinity constant for the first kinetic binding step, k +2 is the on rate of the second binding step, and k À2 is the off rate of the second binding step.
The calculated values for the tubulin oligomers and for the T 2 R complex are fairly similar (K a1 1.9 ± 0.8 3 10 4 M À1 versus 2.3 ± 0.9 3 10 4 M À1 and k +2 5 ± 1 3 10 3 s À1 versus 4 ± 1 3 10 3 s À1 , respectively), suggesting that the oligomerization step required to form the binding site is very fast and cannot be observed. However, the extrapolation to zero ligand concentration of the observed kinetic rate was too imprecise to allow the accurate determination of the k À2 value. Thus k À2 was determined from the kinetics of the dissociation reaction from the T 2 R complex ( Figure 5C ). The observed reaction followed a monoexponential decay with a k À2 of 3.1 ± 0.1 3 10 À4 s À1 , and permits to estimate an overall binding constant of 3 ± 2 3 10 5 M À1 for the process.
The equilibrium binding constants of compounds 1-5 were then measured by analytical ultracentrifugation, which makes it possible to determine the average sedimentation coefficient of a sample (Stafford and Sherwood, 2004) . In turn, by employing average sedimentation coefficient methods, it is possible to determine the apparent self-association constant of the protein in the presence of the ligand, K 2app (scheme inset in Figure 5B ).
Samples of tubulin at concentrations ranging from 0.2 to 10 mM in PEDTA, 1.5 mM MgCl 2 , and 0.1 mM GTP were incubated with 5 mM of the compounds and then analyzed as described in STAR Methods. As expected, the average size of the formed aggregates increased with the concentration of the protein ( Figure 5D ). The analysis of the data allowed the calculation of the apparent isodesmic constants of tubulin association in the presence of the ligands K 2app (1.8 ± 0.3 3 10 5 M À1 for 1, 1.4 ± 0.5 3 10 5 M À1 for 2, 1.0 ± 0.1 3 10 5 M À1 for 3, 1.2 ± 0.2 3 10 5 M À1 for 4, 1.0 ± 0.1 3 10 5 M À1 for 5). The binding affinity of tubulin to self-associate (K 4 in the scheme of the inset of Figure 5B ), 10 4 M À1 in the absence of ligand (Lobert and Correia, 2000) , was increased at least by one order of magnitude in the presence of 1-5.
The experiment was repeated for 1 at ligand concentrations of 2.5 and 10 mM. The analysis allowed to discriminate the K 1 (binding constant of the ligand to tubulin in Figure 5B scheme) from the K 2 (the isodesmic association constant of the ligated protein in Figure 5B scheme) values. The fitting of the experimental datasets provided the corresponding K 1 = 2 ± 1 3 10 6 M À1 and K 2 = 2.1 ± 0.4 3 10 5 M À1 at 25 C. It should be mentioned that with these kinetic and analytical ultracentrifugation methods in combination with the experimental setup, the estimated errors for the obtained values are high. A more accurate measurement could be obtained from the direct determination of the binding affinity of 1 for the T 2 R complex using analytical centrifugation (Fig-ure S4 ). In this experiment, the concentration of the ligandbound and -free T 2 R species is measured, allowing the direct determination of the value for the binding constant of the ligand to the site at 25 C (1.8 ± 0.2 3 10 5 M À1 ), which is in good agreement with the one determined using kinetic methods (see above).
Together, the data obtained show that the TPs bind with micromolar affinities to an interdimer binding site. The binding of compounds results in an enhancement of tubulin-tubulin interactions, which explains the observed induction of tubulin oligomer formation.
Crystal Structure of the Tubulin-1 Complex To analyze the interaction between TPs and tubulin to high resolution, we soaked crystals of a complex formed between two ab-tubulin dimers, the stathmin-like protein RB3 and tubulin tyrosine ligase (T 2 R-TTL; Prota et al., 2013a Prota et al., , 2013b with 1, and solved the structure of the T 2 R-TTL-1 complex by X-ray crystallography at a resolution of 2.4 Å (Table S1) . Unambiguous difference electron density for 1 was observed at the interface between the b1and a2-tubulin subunits of the T 2 R-TTL-1 complex ( Figure 6A ), which permitted us to model the drug molecule confidently (Figures 6B and S6A) . 1 binds to the vinblastine site, only between two longitudinally aligned tubulin dimers and close to the bound GDP nucleotide of the b1-tubulin subunit (Gigant et al., 2005) . The binding site for 1 is formed by residues stemming from helices H6 and H7 and the loop T5 of b1-tubulin, and helix H10 and loop T7 of a2-tubulin ( Figures  6B, 6C, and 6D) .
1 is composed of a pyrimidine core that is substituted with azabicyclo and trifluorophenyl groups (Figures 1 and S6A) . The pyrimidine core of 1 is involved in a p-p stacking interaction with the side chain of bY224 and the guanine nucleobase of the GDP nucleotide. The oxygen atom of the bY224 side chain is involved in hydrogen bond interactions with the nitrogen atom of the azabicyclo group of 1 and the N9 atom of the GDP. The 5 0 -chlorine atom of the pyrimidine group establishes hydrogen bonds with the main-chain nitrogen of bT223, aY357 is involved in a water-mediated interaction with the N3 atom of the pyrimidine ring, and aP325 and aI355 mediate hydrophobic interactions with the pyrimidine group of 1 ( Figure 6C ). The azabicyclo group is accommodated by hydrophobic interactions with aV328 and aI332 of helix H10 of a2-tubulin, and bV177 and bD179 of the b1 tubulin ( Figure 6C ). The three fluorine atoms of the trifluorophenyl group are involved in hydrogen bond interactions with the side chains of aN329 and bN206, and the main chain of bE207 ( Figure 6D ). All residues of the binding site are conserved among all of the tubulin isotypes present in the Bos taurus brain from which the tubulin was purified. Additional support for the binding mode of 1 to tubulin is provided by STD-NMR spectroscopy with tubulin only. The STD experiments indicated that the trifluorophenyl, triazol, and methoxy moieties of the azabicyclo ring of 1 provide the major contacts with tubulin (Figure S5) , which is consistent with the crystal structure.
Interestingly, the overall structure of the T 2 R-TTL-1 complex superimposed poorly with that obtained in the absence of the ligand (root-mean-square deviation [RMSD] of 1.98 Å over 2,146 Ca atoms; PDB: 4IHJ), while the individual tubulin dimers align well (RMSD of the first tubulin dimer a1-b1: 0.72 Å over 836 Ca atoms; RMSD of the second tubulin dimer a2-b2: 0.35 Å over 716 Ca atoms between T 2 R-TTL-1 and T 2 R-TTL). This observation indicates that the binding of 1 significantly alters the relative orientation of the two tubulin dimers, straightening the T 2 R-TTL-1 complex with respect to T 2 R-TTL, but without changing the conformations of the individual tubulin dimers (Figure 7A) . Together, these data demonstrate that TPs bind to the interfacial vinblastine site on tubulin.
Comparison of the Tubulin-Binding Mode of TPs with Other Vinblastine-Site Ligands
To compare the binding mode of TPs with that of well-established microtubule-destabilizing vinblastine-site ligands, we superimposed the b1-tubulin subunits on the T 2 R-TTL-1 structure to the ones crystallized in the presence of vinblastine (PDB: 5J2T), eribulin (PDB: 5JH7), and DZ-2384 (PDB: 5LOV) (Doodhi et al., 2016; Waight et al., 2016; Wieczorek et al., 2016) . We found that most of the residues of b1and a2-tubulin involved in the interaction with 1 also contact vinblastine, eribulin, and DZ-2384 ( Figures 6B, 6C, and 6D) . Eribulin makes additional interactions with the GDP of b1-tubulin and only partially overlaps with 1 ( Figure 7C ). Therefore, we used only vinblastine and DZ-2384 in our further analysis. We found that 1 displays the most compact structure, followed by DZ-2384 and vinblastine ( Figure 7C ). It has been recently shown that DZ-2384, because of its more compact structure, also changes the overall orientation of two adjacent tubulin dimers in the T 2 R-TTL structure, resulting in a less curved complex (Wieczorek et al., 2016) . Such a change in the curvature of tubulin dimers was not observed in T 2 R-TTL-vinblastine or T 2 R-TTL-eribulin complexes compared with apo T 2 R-TTL (not shown). Interestingly, we observed a more drastic change in the orientation of adjacent tubulin dimers in T 2 R-TTL-1 compared with T 2 R-TTL-DZ-2384 (6.49 between T 2 R-TTL-1 and T 2 R-TTL; 3.91 between T 2 R-TTL-DZ-2384 and T 2 R-TTL), leading to a shift of $8.5 Å of the aH10 helix of a2-tubulin between the T 2 R-vinblastine (or T 2 R-TTL, not shown) and T 2 R-TTL-1 structures (Figures 7B and  7D) . Due to the movement of the aH10 and bH6 helices, the bH6-H7 loop is displaced in the tubulin-1 structure compared with the ones obtained with DZ-2384 or in the absence of any ligand ( Figure 7D ). This structural change can be explained by the existing local differences in the binding modes of 1, DZ-2384, and vinblastine despite all three ligands sharing the same overall binding site. First, 1 and DZ-2384 are involved in extensive p-p stacking and hydrogen bonding interactions with residue bY224 and the GDP nucleotide of b1-tubulin. In contrast, vinblastine predominantly establishes hydrophobic contacts with the same moieties ( Figure 7C ). Second, vinblastine lacks the trifluorophenyl group of the pyrimidine core, which is oriented outside the vinblastine site and interacts with residues stemming from both a2and b1-tubulin subunits (Figures 6D  and 7C ). Third, the overall bound structure of 1 is relatively flat compared with the bulkier DZ-2384 and vinblastine molecules ( Figure 7C ). These observations highlight the inherent flexibility of the T 2 R-TTL crystal system, which allows alternative arrangements of tubulin dimers depending on the properties of a ligand bound to the vinblastine site.
Modeling of TPs in the Context of a Microtubule
It has been shown previously that tubulin dimers can have variable curvatures in different T 2 R complex systems (Mignot et al., 2012; Nawrotek et al., 2011) . Vinblastine-site ligands typically depolymerize microtubules by acting as ''wedges'' that prevent 4IHJ) . The b1-tubulin subunits were superimposed using the ''align'' command in PyMol. Red helix, RB3 from T 2 R-TTL; green helix, RB3 from T 2 R-TTL-1. The tubulin dimers from the T 2 R-TTL-1 complex structure are shown as ribbons. TTL and tubulin from T 2 R-TTL (PDB: 4IHJ) are not shown for clarity. (B) Superimposition of T 2 R-TTL-1 onto T 2 R-vinblastine. The superimposition was performed on the corresponding b1-tubulin subunits. GDP, orange sticks; 1, yellow sticks; vinblastine, magenta sticks; b1-tubulin, white surface; gray helix, helix H10 of a2-tubulin in the complex with vinblastine; red helix, helix H10 of a2-tubulin in the complex with 1. (C) A superimposition of tubulin-vinblastine (purple sticks), tubulin-eribulin (green sticks), tubulin-DZ-2384 (blue sticks), and tubulin-1 (yellow sticks). Superimposition was performed on b1-tubulin. Only the ligands are shown. (D) Movements in the bH6 helix and the bH6-bH7 loop of b1-tubulin due to the displacement of helix aH10 of a2-tubulin. The superimposition was performed on the corresponding b1-tubulin subunits. Only representative secondary structure elements are shown and are colored according to the bound ligand: T 2 R-TTL-1 (yellow), T 2 R-TTL-DZ2384 (blue), and T 2 R-TTL (white). (E) Binding site of 1 in T 2 R-TTL crystals (left panel), energy minimized binding site in GMPCPP microtubules (middle panel), and native binding site in GMPCPP microtubules (right panel). b1-Tubulin subunits were used for the superimposition of T 2 R-TTL-1 complex with GMPCPP microtubules (PDB: 3J6E). See also Figure S6 . protofilament straightening and, thus, formation of microtubules (Cormier et al., 2010) . However, although assembly of tubulin in the presence of a stoichiometric amount of 1 leads to aberrant polymers, it is readily able to bind preformed microtubules both in vitro and in cells, which is not the case for vinblastine (see above) or DZ-2384 (Wieczorek et al., 2016) . To obtain structural insights into this issue, we computationally investigated whether 1 could bind to its binding site in the context of atomic models of microtubules derived from cryo-electron microscopy reconstructions. Two distinct lattice arrangements are known based on microtubule structures obtained in the presence of either GTP (GDP microtubules) or GMPCPP (GMPCPP microtubules), a slowly hydrolyzable GTP analog (Alushin et al., 2014; Zhang and Nogales, 2015) . We observed that 1 could easily be accommodated into the GMPCPP-microtubule model by only minor movements of side chains of very few residues in its binding site ( Figure 7E) . The computational analysis also suggests that the compaction in the microtubule lattice that is thought to take place upon GTP hydrolysis in b-tubulin (Alushin et al., 2014; Zhang and Nogales, 2015) could make the accommodation of 1 into its binding site in the context of the GDP-microtubule model more difficult (not shown). Although the microtubule shaft is mainly composed of GDP-tubulin except for the GTP-cap present at microtubule tips, it is known that binding of some drugs reverts this compaction (Alushin et al., 2014) , indicating that the longitudinal lattice spacing between dimers is somehow flexible. Thus, it is reasonable to assume that the binding of the compound could reverse the compaction of the lattice, resulting in a more stable GTP-like microtubule lattice state. However, the binding of the compounds to the GTP-like microtubule interface, although possible, may require a small expansion and distortion of the interface, which may need to be compensated by the next interface to keep the microtubule lattice stable. This hypothesis is supported by the fact that the compound is unable to bind to crosslinked microtubules, whose interfaces are stabilized. Such compensation could inhibit the binding of the compound to the next consecutive interdimer interface, resulting in a binding stoichiometry of one molecule of compound per every second interface, which is in line with the observed stoichiometry of 0.6-0.7. Notably, since local uncertainties in the available $5-Å resolution cryo-electron microscopy microtubule structures cannot be ruled out, our computational analysis relies on the accuracy of the microtubule models used.
Together, this analysis indicates that due to the compact structure and smaller size, TPs do not act as classical vinblastine-site wedges but can be accommodated at the longitudinal interdimer tubulin interface in microtubules. Such a mechanism would readily explain the MSA-like properties of TPs.
Modeling of 2-5 in the Vinblastine Site of Tubulin
To provide a mechanistic explanation for the differences observed in potency between the five TP compounds analyzed here, we modeled complexes between tubulin and 2-5 using the determined structure of the T 2 R-TTL-1 complex. The calculated structure of the complexes of T 2 R-TTL with compounds 2-5 indicated that all the ligands strictly occupy the same binding pocket, as expected by their identical cellular and biochemical modes of action. The comparison of the structures indicates only minor differences in the angle between the azabicycle group and the pyrimidine core ( Figure S6B) . Given the fact that the hydrophobic pocket where the azabicycle group binds is relatively large, it provides enough space to easily accommodate the different substituents present in compounds 2-5 without appreciable changes in their binding affinities. Thus the differences in cytotoxicity observed cannot be assigned to different binding modes of the different compounds to tubulin, but more likely to differences in cell intake, potency with respect to assembly induction, or solubility of the compounds.
SIGNIFICANCE
The herein described TPs constitute a family of MSAs that are unrelated to taxane-and laulimalide/peloruside-site agents. Remarkably, TPs display a different molecular mechanism of action compared with these other MSAs: they stabilize longitudinal instead of primarily lateral tubulin contacts in microtubules . The T 2 R-TTL-1 crystal structure revealed that 1 binds to a tubulin-site that overlaps with the vinblastine- (Gigant et al., 2005) and eribulin-sites (Doodhi et al., 2016) , both targeted by tubulin assembly inhibitors. However, the cellular and biochemical effects of TPs resemble those of MSA. Similar to vinblastine-site binders (Lobert et al., 1996) , TPs induce tubulin oligomerization, in line with the fact that the site is formed at the longitudinal interface between two longitudinally aligned tubulin dimers. However, although they perturb the assembly of tubulin into microtubules, they are able to bind preassembled microtubules without significantly affecting their structures. How is it possible that a vinca-site binder acts as an MSA? The structure of the T 2 R-TTL-1 complex sheds some light on this question. Although vinblastine-site binders act classically as ''wedges'' that prevent the straightening of tubulin protofilaments (Gigant et al., 2005) , a process essential for microtubule formation, the smaller and flatter structure of TPs results in an overall straighter T 2 R-TTL-1 complex structure compared with T 2 R-TTL or T 2 R-TTL-vinblastine. The flat structure of TPs allows them to accommodate at the longitudinal interdimer interface in microtubules, acting as ''matchmakers'' instead of as wedges. Finally, it should be noted that the TPs studied here are not affected by p-glycoprotein overexpression, being equally effective in resistant and non-resistant cells. These results suggest that TPs are promising novel chemotypes with both the potential to pass the blood-brain barrier and thus to access brain tumors, and be effective against cancer cells resistant to chemotherapy through a multidrug-resistance mode of action.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Human A549 non-small lung carcinoma cells and human ovarian carcinomas A2780 and A2780AD (MDR overexpressing P-glycoprotein) were cultured at 37 C in RPMI-1640 supplemented with 10% fetal calf serum, 2 mM L-glutamine,40mg/ml gentamycin, 100 IU/ml penicillin, and 100 mg/ml streptomycin in a 5% CO2 air atmosphere as previously described (Buey et al., 2007) . REAGENT 
METHOD DETAILS Proteins
Calf-brain tubulin was purified by ammonium sulfate fractionation of calf brain extracts followed by a batch anion exchange chromatography in DEAE-Sephadex, and a MgCl 2 precipitation, following a modified Weissember protocol (Weisenberg et al., 1968) as described in (Andreu, 2007) , pure protein was conserved cryopreserved in liquid nitrogen. Microtubular protein, containing tubulin and MAPs, was prepared by cycles of assembly and disassembly as described in (de Pereda et al., 1995) and cryopreserved in liquid nitrogen. Stabilized, moderately crosslinked MTs were prepared by mild glutaraldehyde fixation of glycerol induced putified tubulin microtubules as reported earlier (Díaz et al., 2003) which were drop frozen and cryopreserved in liquid nitrogen. The stathmin-like domain of rat RB3 was cloned in a pET3d vector and overexpression of the protein was performed in E.coli BL21DE3 cells for 4h at 37 C. The protein was prepared accordingly to (Ravelli et al., 2004) . Briefly, cells were lysed by sonication and the lysate was cleared by centrifugation. The supernatant was boiled 10 min and centrifugated once more. The protein was loaded on a Q-sepharose ion exchange column and elution was performed by a NaCl gradient. Fractions containing the RB3 protein were pooled, concentrated and loaded on a S75 16/60 Sepahrose size exclusion chromatography column. Pure RB3 protein was concentrated and flash frozen in liquid nitrogen.
Chicken TTL was cloned with a C-terminal hexahistidine tag in a pET based vector (Olieric et al., 2010) . Preparation of the protein has been described in . Briefly, the protein was overexpressed in E. coli BL21DE3 cells over-night at 20 C. The cells were lysed by sonication and the cleared lysate was loaded on HisTrap affinity column. The fractions containing the ggTTL protein were pooled, concentrated and injected on a S200 16/60 Sepahrose size exclusion chromatography column. The pure protein was concentrated and flash frozen in liquid nitrogen.
Ligands
Compounds 1-5 ( Figure 1) were synthesized as described (Lamberth et al., 2006) and its identity confirmed by NMR, they were dissolved in D6-DMSO at a 20 mM concentration and stored at -80 C. The compounds were analyzed using an Agilent 1100 chromatograph connected to a reverse phase column Zorbax Eclipse XDB-C18 (mobile phase 70% Methanol in water for 20 minutes) coupled to a Agilent 6120 mass spectrometer. All the compounds were found more than 95% pure and their determined molecular weights were found. Their ultraviolet-visible absorbance spectrum was determined in spectroscopic degree ethanol in an Evolution 201 (Thermo Scientific) UV-Visible spectrometer, showing the following absorbance maxima 1 ε 320 20000 ± 500 M -1 cm -1 , 2 ε 319 17100 ± 100 M -1 cm -1 , 3 ε 319 16800 ± 700 M -1 cm -1 , 4 ε 320 15500 ± 600 M -1 cm -1 , 5 ε 318 14500 ± 300 M -1 cm -1 . Their solubility in water was determined by centrifuging at 110000 g, 50 mM samples stored in polypropylene, and glass tubes in 3.4 M Glycerol, 10 mM Sodium Phosphate, 1 mM EGTA, 6 mM MgCl 2 pH 6.5 buffer supplemented with 0.1 mM GTP. The concentration of compound in solution was determined spectrophotometrically before and after centrifugation. All the compounds were found soluble at 50 mM except 4 whose solubility was found to be 20 mM.
Vinblastine was from Sigma-Aldrich, Laulimalide was kindly provided by Dr. Peter T. Northcote (Victoria University of Wellington), Flutax-2 was kindly provided by Dr. Wei-Shuo Fang (Institute Materia Medica. Beijing), Paclitaxel was kindly provided by the National Cancer Institute (Bethesda, USA), Docetaxel was kindly provided by Rhô ne Poulenc Rorer, Aventis (Schiltigheim, France). Cell Biology Assays Indirect Immunofluorescence A549 cells were plated at a density of 130,000 cells/ml onto 12 mm round coverslips, cultured overnight, and then treated with the ligands at different concentrations or drug vehicle (DMSO) for 24 hr. Residual DMSO was less than 0.5%. Attached A549 cells were permeabilized with Triton X-100 and fixed with 3.7% formaldehyde, as previously described (de Ines et al., 1994) . Cytoskeletons were incubated with a DM1A monoclonal antibody reacting with a-tubulin, washed twice, and incubated with FITC goat anti-mouse immunoglobulins. The coverslips were washed, 1 mg/ml Hoechst 33342 was added to stain chromatin, washed, examined, and photographed with a Zeiss Axioplan epifluorescence microscope, and the images were recorded with a ORCH-FLASH 4.0 cooled CCD camera. Cell Cytotoxicity Assay Cells were seeded in 96-well plates at a density of 10,000-15,000 cells in 80 ml per well. On the next day, cells were exposed to 20 ml serial dilutions (0.005 nM-40 mM) of ligands for 48 hr, at which time an MTT assay was performed to determine viable cells with some modifications. Briefly, 20 ml of 2.5 mg/ml MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) was added to each well, incubated for 4 hr at 37 C, and then treated with 0.1 ml MTT solubilizer (10% SDS, 45% dimethylformamide [pH 5.5]). Plates were again incubated overnight at 37 C to solubilize the blue formazan precipitate before measuring the absorbance at 595/690 nm in an Appliscan microplate reader (Thermo Fisher, Waltham, Massachusetts, USA) . Control wells containing medium without cells were used as blanks. The MTT response is expressed as a percentage of the control (untreated) cells. The IC 50 was calculated from the log-dose response curves. Cell Cycle Analysis Progression through the cell cycle was assessed by flow cytometry DNA determination with propidium iodide (Buey et al., 2005) . A549 cells (160,000 per ml) were seeded and incubated overnight, then several concentrations of the drugs were added and the cells were incubated for further 20 h. The cells were trypsinized and washed, fixed for more than 4 h with 70% ethanol, washed with PBS, treated with RNase, and stained with propidium iodide; analysis was conducted with a Coulter Epics XL flow cytometer.
NMR Characterization of the Compounds
Reversibility of the Effect of the Compounds
The reversibility of the effect of the compounds was tested in Aspergillus nidulans cultures, fungal cells were cultured in Watch Minimal Media (WMM) as described (Peñ alva, 2005) . Once grown up they were incubated for 30 min at 28 C in the presence of 20 mM of 1. Then the media was replaced by fresh one. Pictures were taken with a Leica DMI6000-B epifluorescence microscope equipped with a CCD Hamamatsu ORCA-ERII camera with a 63x objective.
Tubulin Polymerization Assays
Tubulin polymerization in the presence of the compounds in GAB buffer (3.4 M glycerol, 10 mM sodium phosphate (NaPi), 1 mM EGTA, 6 mM MgCl 2 , 1 mM GTP, pH 6.7) and PEDTA 7 (10 mM sodium phosphate (NaPi), 1 mM EDTA, 7 mM MgCl 2 , 1 mM GTP, pH 6.7) was measured as reported earlier (Buey et al., 2005) .
Time courses of binding of 20 mM tubulin in GAB buffer were followed by turbidity at 350 nm employing a Thermo Appliskan plate reader (Thermo Fisher, Waltham, MA, USA).
Determination of the Stoichiometry
The stoichiometry of binding of 1 and vinblastine to the tubulin polymers and microtubules was measured with a centrifugation assay. 20 mM tubulin in GAB buffer was incubated at 37 C for 45 minutes in the presence and absence of 20 mM 1 or vinblastine, or with growing amounts of 1-5 up to 75 mM. Once assembled the samples incubated in the absence of drugs were added 20 mM 1 or vinblastine and further incubated at 37 C for 45 min. Then the samples were centrifuged for 20 min at 50,000 rpm in a Beckman Optima TLX in 1ml polycarbonate tubes, the supernatant was carefully collected and the pellet was resuspended in 1 ml of 10 mM Sodium phosphate pH 7.0, and both pellet and supernatants were extracted with 3 volumes of dichloromethane after addition of 10 mM docetaxel as internal standard. The samples were dried, dissolved in the mobile phase and analyzed in a using an Agilent 1100 chromatograph connected to a reverse phase column Zorbax Eclipse XDB-C18 (mobile phase 25% Acetonitrile 10 minutes, gradient from 25 to 75% 30 minutes, 75% acetonitrile 10 minutes) with detection at 254, 273 and 320 nm.
Kinetics of Binding and Dissociation to Tubulin
The kinetics of binding and dissociation of 1 to tubulin and the T 2 R complex were measured in a Horiba Jovin-Yvon Fluoromax-2 with excitation at 320 nm and emission at 460 nm. To measure the association kinetics samples of tubulin (2 mM) in PEDTA1.5 or T 2 R complex (1 mM obtained by mixing 2 mM tubulin with 3 mM RB3) in 10 mM Sodium Phosphate, 0.1 mM DTT, 1.5 mM MgCl 2 0.1 mM GTP pH 6.5 buffer (NAPI-DTT1.5) were supplemented with 1 at 20, 30, 40, 50 or 60 mM and the fluorescence of the sample measured at 25 C. To measure the dissociation kinetics a sample of tubulin (2 mM) in PEDTA1.5 or T 2 R complex (1 mM) in NAPI-DTT1.5 preincubated with 2 mM of 1 was supplemented with 100 mM vinblastine and the fluorescence of the sample measured at 25 C.
Analytical Ultracentrifugation
Samples of GTP-tubulin equilibrated in 10 mM Sodium Phosphate, 1 mM EDTA 0.1, mM GTP (PEDTA) or GDP-tubulin prepared as described (Díaz and Andreu, 1993) and equilibrated in 10 mM Sodium Phosphate 1 mM, EDTA 0.1 mM GDP (PEDTA-GDP) (Díaz and Andreu, 1993) and supplemented with the desired MgCl 2 or ligand concentrations were analyzed in a Beckman Optima XL-I ultracentrifuge equipped with dual detection system, one of UV-visible absorbance and another by Rayleigh interference (Philo, 2009 ). An angular speed of 45krmp (163.300 g) and a An50Ti rotor equipped with a 1.2 cm optical pathway double sector cells with quartz windows.
The obtained sedimentation profiles were analyzed as described (Brown and Schuck, 2008; Schuck, 2000) and the average sedimentation coefficient c(s) was calculated using Sedfit (Schuck and Demeler, 1999) . The data obtained were corrected by the density and viscosity of the media using Sednterp (Laue et al., 1992) Calculation of the Apparent Binding Constants of the Ligands to Tubulin The apparent binding constants of ligands to tubulin was calculated using SwKeq (Rodríguez-Salarichs, J. and Díaz, J.F.).
Once the apparent binding constants are determined the free ligand concentration in the experiments is necessary to calculate the two individual binding constants K 1 (the association constant of the ligand for the protein) and K 2 the autoassociation constant of the protein from the K 2app determined according to the Equation S5:
The free ligand concentration was determined by centrifugation an aliquot of the sample in a Beckman Optima TLX. A 200 ml sample was centrifuged at 100.000 rpm in a TLA100 rotor for 2 h and the upper and the lower half of the tube carefully collected. The upper part of the tube was found free of tubulin so the free concentration of ligand can be determined from the upper part of the tube by HPLC as described above.
Alternatively the binding constant of compound 1 to the T2R complex has been calculated as follows, assuming a stoichiometry of one molecule of 1 per molecule of T2R complex. The area under the 9S peak in the c(s) distribution of the ligand and initial scans at 3,000 rpm were employed to calculate the fraction of ligand co-sedimenting with the protein (3.1±0.1 mM, average of 3 independent measurements), employing an extinction coefficient e 320 20000 ± 500 M -1 cm -1 (all determined extinction coefficients are presented in the the Ligands section of STAR Methods) (Barbier et al., 2010) . The solubility of the compound was previously determined to be higher than 50 mM as described in Ligands. The concentration of sedimenting T2R complex (5.1±0.1 mM) was calculated from the integral of the area under the T2R peak (9 S) in the c(s) distribution of the protein (average of 3 independent measurements), employing a factor of 3.25 fringes per mg/ml of protein (Laue, 1996) . This was found to be coincident with the expected 5 mM of T2R complex when 10 mM tubulin is incubated with 7.5 mM RB3.
Electron Microscopy
Polymers of tubulin at 10 mM concentration, in different buffer conditions, were fixed with 0.1% Glutaraldehyde. Reaction was stopped with 100mM Glycine. 4 ml sample was deposited on carbon-coated 400 mesh grids and were negatively stained using 2% (w/v) uranyl acetate. Micrographs were recorded using a JEOL 1230 transmission electron microscope at 100 KeV and a 16 megapixel TemCam-F416 CCD camera from TVIPS.
A549 lung carcinoma cells were plated at a density of 180000 cells/ml in 6 well plates, grown overnight and then treated with either paclitaxel (500nM), 1 (1 mM or 20 mM) or drug vehicle (DMSO). 20 hours later the cells are washed (PBS), fixed with 3% glutaraldehyde (1h, RT), washed and then postfixed with 1 % osmium and 0.8% ferrocyanide (1h, 4 C), washed and dehydrated with ethanol in a 30%-100% gradient and embedded in epoxy resin. Images were acquired at 80kV with the electron microscope described above.
Molecular Modeling
For comparing relative orientation of adjacent tubulin dimers between T 2 R-TTL-1, T 2 R-TTL-DZ2384 and T 2 R-TTL, structures were aligned on b1 tubulin and three helices were defined (RB3, chain E; amino acids 100-141). Angles between defined helices were calculated using anglebetweenhelices.py script in PyMOL. 1 was modeled in GDP-(PDB ID 3J6F) and GMPCPP-microtubules (PDB ID 3J6E) using Moloc (Gerber Molecular Design, Switzerland) . We first modeled 1 into the structure of GDP-or GMPCPP-microtubules and minimized the modeled binding pocket in the presence of the ligand by using MAB force field in Moloc (Gerber and Muller, 1995) . Only side chains of the amino acids in the binding pocket were relaxed in order to accommodate the ligand while keeping the Ca-backbone fixed.
Models of compounds 2-5 bound to tubulin were built departing from the crystal structure of the T 2 R-TTL-1 complex using Autodock version 4.2 (Morris et al., 1998) . The structure of the protein was kept rigid while this of the ligands was allowed to be flexible. Redocking of 1 was used to optimize docking parameters.
QUANTIFICATION AND STATISTICAL ANALYSIS
IC 50 data are presented as mean ± SE of triplicated experiments. Tubulin polymerization data are plotted as mean ± SE of triplicated experiments. Stoichiometry and ligand binding to tubulin values are presented as mean ± SE of triplicated experiments. Average diffusion coefficients are single measurement data. The observed kinetic association and dissociation rates of 1 to/from tubulin are presented as mean ± SE of triplicated experiments. Apparent isodesmic constants of tubulin association in the presence of the ligands, binding constants of the ligand to tubulin and isodesmic association constant of the ligated protein are presented mean ± SE of duplicated experiments. The binding constant of the ligand to the site in the T2R complex is presented as mean ± SE of triplicated experiments.
DATA AND SOFTWARE AVAILABILITY
The structure of T 2 R-TTL-1 has been deposited to the PDB under the accession number 5NJH.
SwKeq (Rodriguez-Salarisch, J. and Díaz, J.F.) analyzes systems in which proteins associate in a isodesmic way (the binding constant of each polymerization step is identical).
) Equation S1 correlates the total concentration of protein Ct with this of the unoligomerized species Ci on depending on the ki, the equilibrium binding constant of two protein subunits, so called the isodesmic constant. Given an isodesmic system the concentration of any species can be calculated from the concentration of the dimer.
Being c I the concentration of the i-meric species and K I the global equilibrium constant of a system with i degrees of polymerization. This global equilibrium constant K I is the product of all the intermediate step constants, which in an isodesmic system are all equal, allowing the determination of the concentration of all the species present in the system and thus of the average sedimentation constant of it (Lobert and Correia, 2000) following the equations: Which calculates the average sedimentation coefficient corrected to 20 C s 20;w , s 0 i the sedimentation coeficient of a i-mer and GI a constant of value 0.018mL/mg, which correctes for the non linear effect of the protein concentration (Sontag et al., 2004) .
SwKeq fits iteratively the ki (the apparent autoassociation constant of the protein in the presence of the ligand, K 2app ) value for a set of experiments at equal MgCl 2 concentration to obtain the best correlation between the experimentally determined average sedimentation coefficient and the calculated one allowing the determination of apparent autoassociation constant of the protein.
SwKeq can be downloaded from https://github.com/rodriguez-salarichs/SwKeq.
